Details:

Alternative Title:
MMWR Morb Mortal Wkly Rep
Personal Author:
Sosa, Lynn E. ; Njie, Gibril J. ; Lobato, Mark N. ; Bamrah Morris, Sapna ; Buchta, William ; ... More +
Sosa, Lynn E. ; Njie, Gibril J. ; Lobato, Mark N. ; Bamrah Morris, Sapna ; Buchta, William ; Casey, Megan L. ; Goswami, Neela D. ; Gruden, MaryAnn ; Hurst, Bobbi Jo ; Khan, Amera R. ; Kuhar, David T. ; Lewinsohn, David M. ; Mathew, Trini A. ; Mazurek, Gerald H. ; Reves, Randall ; Paulos, Lisa ; Thanassi, Wendy ; Will, Lorna ; Belknap, Robert ; Less -
Corporate Authors:
National Tuberculosis Controllers Association. ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. ; National Institute for Occupational Safety and Health. Respiratory Health Division. ; National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. ;
National Tuberculosis Controllers Association. ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. ; National Institute for Occupational Safety and Health. Respiratory Health Division. ; National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. ; Less -
Description:
The 2005 CDC guidelines for preventing Mycobacterium tuberculosis transmission in health care settings include recommendations for baseline tuberculosis (TB) screening of all U.S. health care personnel and annual testing for health care personnel working in medium-risk settings or settings with potential for ongoing transmission (1). Using evidence from a systematic review conducted by a National Tuberculosis Controllers Association (NTCA)-CDC work group, and following methods adapted from the Guide to Community Preventive Services (2,3), the 2005 CDC recommendations for testing U.S. health care personnel have been updated and now include 1) TB screening with an individual risk assessment and symptom evaluation at baseline (preplacement); 2) TB testing with an interferon-gamma release assay (IGRA) or a tuberculin skin test (TST) for persons without documented prior TB disease or latent TB infection (LTBI); 3) no routine serial TB testing at any interval after baseline in the absence of a known exposure or ongoing transmission; 4) encouragement of treatment for all health care personnel with untreated LTBI, unless treatment is contraindicated; 5) annual symptom screening for health care personnel with untreated LTBI; and 6) annual TB education of all health care personnel.
Subject:
[+]
Full Report
Health Personnel
Humans
Interferon-gamma Release Tests
Latent Tuberculosis
Mass Screening
Mycobacterium Tuberculosis
Risk Assessment
Systematic Reviews As Topic
Tuberculin Test
Tuberculosis

Source:
MMWR Morb Mortal Wkly Rep. 68(19):439-443 ;
Pubmed ID:
31099768
Pubmed Central ID:
PMC6522077
Document Type:
Journal Article ;
Genre:
Practice Guideline ;
Place as Subject:
United States ;
Collection(s):
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:fe7f92de4231b6212f1505626005ca73986103b7c34e734c1dbc412d24cc21b5
File Type:

Supporting Files

• mm6819a3.nxml

  xml

More +